Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00912977 · ClinicalTrials.gov registry record

Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

A clinical trial of Parkinson's Disease, sponsored by Oregon Health and Science University.

Completed
Registry status
10
Enrollment target
1
Study location

NCT00912977 is a study of Parkinson's Disease that has completed, run by Oregon Health and Science University. The registered enrollment target is 10 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00912977, a study of Parkinson's Disease, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

Nearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa. The severity of these movements can range from subtle to extremely debilitating and may or may not interfere with normal activities such as putting on a coat or brushing ones teeth. The purpose of this study is to demonstrate the validity and reliability of objectively measuring dyskinesia with a forceplate.

Conditions Studied

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2009-06
Est. Completion 2010-06

What the Registry Record Tells You About NCT00912977

The ClinicalTrials.gov registry entry for NCT00912977 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (98% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00912977 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT00912977 about?

NCT00912977 is a clinical study titled "Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia". Nearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa. The severity of these movements can range from subtle to extremely debilitating and may or may not interfere with normal activities such...

What is the current status of trial NCT00912977?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2009-06. Estimated completion is 2010-06.

What conditions does trial NCT00912977 study?

This clinical trial studies the following conditions: Parkinson's Disease.

Who is sponsoring clinical trial NCT00912977?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00912977 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.